Metraipolis › archive › dc_2b314c2b18f4

Clinical Quality Considerations when Using Next-Generation Sequencing (NGS) in Clinical Drug Development — Europe PMC PMID:34046876

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/34046876
DOI
10.1007/s43441-[numero omesso]-6
License (as archived)
solo-consultazione
Archived
2026-10-08T11:21:58.985Z
SHA-256 of the archived text
038c7efa480da560a0a915cd658abd284df42b92993f322736faeb32228057d8
Stable URL of this page
https://metraipolis.com/documento/dc_2b314c2b18f4

How to cite

Clinical Quality Considerations when Using Next-Generation Sequencing (NGS) in Clinical Drug Development — Europe PMC PMID:34046876 — Europe PMC (en), https://europepmc.org/article/MED/34046876 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_2b314c2b18f4 (Metraipolis archive dc_2b314c2b18f4, sha256 038c7efa480da560a0a915cd658abd284df42b92993f322736faeb32228057d8)
BibTeX
@misc{dc2b314c2b18f4,
  title = {Clinical Quality Considerations when Using Next-Generation Sequencing (NGS) in Clinical Drug Development — Europe PMC PMID:34046876},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/34046876},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_2b314c2b18f4; sha256 038c7efa480da560a0a915cd658abd284df42b92993f322736faeb32228057d8},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/34046876. Agents can read the archived copy with the MCP tool read_document.